Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges
Celina Dubin, Ester Del Duca, Emma Guttman‐Yassky
Therapeutics and Clinical Risk Management (2020) Vol. Volume 16, pp. 1319-1332
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

The JAK/STAT signaling pathway: from bench to clinic
Xiaoyi Hu, Jing Li, Maorong Fu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1422
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials
Robert Bissonnette, Richard B. Warren, Andreas Pinter, et al.
The Lancet (2024) Vol. 404, Iss. 10451, pp. 461-473
Closed Access | Times Cited: 15
Baricitinib treatment of severe chronic hand eczema: Two case reports
Fieke M. Rosenberg, Laura Loman, Marie L. A. Schuttelaar
Contact Dermatitis (2022) Vol. 86, Iss. 5, pp. 419-421
Open Access | Times Cited: 24
A Review of Existing and New Treatments for the Management of Hand Eczema
Jessica S. S. Ho, Sonja Molin
Journal of Cutaneous Medicine and Surgery (2023) Vol. 27, Iss. 5, pp. 493-503
Open Access | Times Cited: 14
Chronic Hand Eczema (CHE): A Narrative Review
G. Ghezzi, Costanza Falcidia, Giovanni Paolino, et al.
Dermatology and Therapy (2025)
Open Access
Chronic Hand Eczema, Real World, and Patient Centricity: A Narrative Review
Sonja Molin, Emma Guttman‐Yassky, Jacob P. Thyssen, et al.
Acta Dermato Venereologica (2025) Vol. 105, pp. adv42596-adv42596
Open Access
Current emerging and investigational drugs for the treatment of chronic hand eczema
Julia Cheng, Paola Facheris, Benjamin Ungar, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 8, pp. 843-853
Closed Access | Times Cited: 22
Health-Related Quality of Life in Chronic Hand Eczema in a Phase 2b Trial of Delgocitinib Cream
Timo Buhl, Andrea S. Bauer, Benjamin D. Ehst, et al.
Dermatology and Therapy (2025)
Open Access
Chronic hand eczema treatment: exploring topical JAK inhibition further
Yael Renert‐Yuval
The Lancet (2025)
Closed Access
Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial
Ana M. Giménez‐Arnau, Andreas Pinter, Wiebke Sondermann, et al.
The Lancet (2025)
Closed Access
Treatment of chronic hand eczema with dupilumab—A retrospective follow‐up study
Caroline Meyer Olesen, Yasemin Topal Yüksel, Claus Zachariae, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 4
Closed Access | Times Cited: 15
New Perspectives in the Management of Chronic Hand Eczema: Lessons from Pathogenesis
Vittorio Tancredi, Dario Buononato, Stefano Caccavale, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 362-362
Open Access | Times Cited: 7
Risk factors that limit use of oral JAK inhibitors in chronic hand eczema: Findings from the Danish Skin Cohort
Y.M.F. Andersen, Johan Sieborg, Lea K. Nymand, et al.
JAAD International (2024) Vol. 17, pp. 61-66
Open Access | Times Cited: 2
Topical and systemic JAK inhibitors in hand eczema – a narrative review
Adam Zalewski, Jacek C. Szepietowski
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 4, pp. 365-373
Closed Access | Times Cited: 6
Evaluating topical JAK inhibitors as a treatment option for atopic dermatitis
Mohammad I. Fardos, Rohan Singh, Patrick O. Perche, et al.
Expert Review of Clinical Immunology (2021) Vol. 18, Iss. 3, pp. 221-231
Closed Access | Times Cited: 13
The management of Chronic Hand Eczema: A retrospective patient record review
Emma Borg, Duncan Munro, Henrik Thoning
Contact Dermatitis (2024) Vol. 90, Iss. 4, pp. 365-371
Open Access | Times Cited: 1
Comparison of the effect of topical triamcinolone 0.1% cream with sulfur 2.0% cream in the treatment of patients with hand eczema: A randomized controlled trial
Ali Asilian, Parisa Mohammadian, Sayed Mohsen Hosseini, et al.
Journal of Cosmetic Dermatology (2024) Vol. 23, Iss. 5, pp. 1753-1757
Open Access | Times Cited: 1
Topical ruxolitinib 1.5% (JAK1/JAK2 inhibitor) improves clinical and patient‐reported outcomes in moderate to severe chronic hand dermatitis: Data from a small open‐label trial
Hannah Smith, J. Lally, Alison Moy, et al.
JEADV Clinical Practice (2024) Vol. 3, Iss. 4, pp. 1016-1026
Open Access | Times Cited: 1
Management of Atopic Hand Dermatitis
Lauren R Port, Patrick M. Brunner
Dermatologic Clinics (2024) Vol. 42, Iss. 4, pp. 619-623
Closed Access | Times Cited: 1
Evaluation of validity, reliability and ability to detect change for the Hand Eczema Severity Index (HECSI) and evaluation of HECSI‐75 and HECSI‐90 as within‐patient responder definitions
Yasemin Topal Yüksel, Henrik Thoning, Lotte Seiding Larsen, et al.
Contact Dermatitis (2024)
Open Access | Times Cited: 1
Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
Lin Deng, Yingzhi Luo, Binyi An, et al.
Clinical Cosmetic and Investigational Dermatology (2022) Vol. Volume 15, pp. 2421-2426
Open Access | Times Cited: 7
Alitretinoin for the treatment of severe chronic eczema of the hands
Maddalena Napolitano, Luca Potestio, Mario De Lucia, et al.
Expert Opinion on Pharmacotherapy (2021) Vol. 23, Iss. 2, pp. 159-167
Closed Access | Times Cited: 9
Eczematous Disorders
Avad Mughal, J.R. Ingram
(2024), pp. 1-41
Closed Access
Hands-on: a novel JAK inhibitor for the treatment of chronic hand eczema
Yael Renert‐Yuval, Emma Guttman‐Yassky
The Lancet (2024) Vol. 404, Iss. 10451, pp. 409-411
Closed Access
Dupilumab for Chronic Hand Eczema: A Systematic Review and Meta-Analysis
Hannah Riva, Teresa Yoon, Aleksi J. Hendricks, et al.
Dermatitis (2024)
Closed Access
Page 1 - Next Page

Scroll to top